blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0518798

EP0518798 - Compositions for use in the treatment of aphtous ulcers and other mucocutaneous disorders [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  26.09.1997
Database last updated on 01.10.2024
Most recent event   Tooltip04.07.2008Change - representativepublished on 06.08.2008  [2008/32]
Applicant(s)For all designated states
CHEMEX/BLOCK DRUG, JV
257 Cornelison Avenue
Jersey City, NJ 07302 / US
[1992/51]
Inventor(s)01 / Vora, Kabubhai Rashmi
924, Pennsylvania Avenue
Westfield, NJ 07090 / US
02 / Khandwala, Atul
1055 River Road, Unit 310
Edgewater, NJ 07024 / US
03 / Smith, Charles G.
17323 Circa-Del Sur
Rancho, Sante Fe, CA 92067 / US
[1992/51]
Representative(s)Poupon, Michel
Cabinet Bleger-Rhein-Poupon
L'Escurial - Technopole de Brabois
17, avenue de la Forêt de Haye
54519 Vandoeuvre-Les-Nancy Cedex / FR
[N/P]
Former [2008/32]Poupon, Michel
Cabinet Michel Poupon L'Escurial - Technopole de Brabois 17 Avenue de la Forêt de Haye
54519 Vandoeuvre-Les-Nancy Cedex / FR
Former [1993/26]Poupon, Michel
B.P. 421 3, rue Ferdinand Brunot
F-88011 Epinal Cédex / FR
Former [1992/51]Poupon, Michel
B.P. 421 3, rue Ferdinand Brunot
F-88011 Epinal Cédex / FR
Application number, filing date92470014.909.04.1992
[1992/51]
Priority number, dateUS1991068234709.04.1991         Original published format: US 682347
[1992/51]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0518798
Date:16.12.1992
Language:EN
[1992/51]
Type: A3 Search report 
No.:EP0518798
Date:07.12.1994
Language:EN
[1994/49]
Search report(s)(Supplementary) European search report - dispatched on:EP20.10.1994
ClassificationIPC:A61K31/33, A61K31/00
[1994/36]
CPC:
A61Q11/00 (EP); A61K31/12 (EP); A61K31/20 (EP);
A61K31/34 (EP); A61K31/35 (EP); A61K31/365 (EP);
A61K31/37 (EP); A61K31/40 (EP); A61K31/41 (EP);
A61K31/415 (EP); A61K31/425 (EP); A61K31/436 (EP);
A61K31/44 (EP); A61K31/495 (EP); A61K31/505 (EP);
A61K31/55 (EP); A61K31/557 (EP); A61K31/685 (EP);
A61K38/04 (EP); A61K8/36 (EP); A61K8/361 (EP);
A61K8/365 (EP); A61K8/44 (EP); A61K8/46 (EP);
A61K8/49 (EP); A61K8/4913 (EP); A61K8/4926 (EP);
A61K8/494 (EP); A61K8/496 (EP); A61K8/4973 (EP);
A61K8/498 (EP); A61K9/006 (EP); A61P1/02 (EP);
A61P43/00 (EP); A61P7/02 (EP); A61K2800/782 (EP) (-)
Former IPC [1992/51]A61K31/33
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1992/51]
TitleGerman:Zusammensetzungen zur Behandlung von aphtösen Ulcera und anderen mucokutanösen Störungen[1992/51]
English:Compositions for use in the treatment of aphtous ulcers and other mucocutaneous disorders[1992/51]
French:Compositions pour le traitement d'ulcers aphteux et d'autres maladies mucocutaneuses[1992/51]
MiscellaneousEPB 1997/43: Teilanmeldung 97202524.1 eingereicht am 15/08/97
EPB 1997/43: Divisional application 97202524.1 filed on 15/08/97
EPB 1997/43: Demande divisionnaire 97202524.1 déposée le 15/08/97
Examination procedure14.04.1993Examination requested  [1993/24]
29.03.1995Despatch of a communication from the examining division (Time limit: M06)
20.11.1995Reply to a communication from the examining division
28.05.1996Despatch of a communication from the examining division (Time limit: M04)
19.09.1996Reply to a communication from the examining division
28.02.1997Despatch of a communication from the examining division (Time limit: M02)
13.05.1997Application deemed to be withdrawn, date of legal effect  [1997/46]
11.06.1997Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [1997/46]
Divisional application(s)EP97202524.1  / EP0836852
EP97470020.5   Application deemed to be withdrawn  : 13.09.1997
Request for further processing for:16.06.1997Request for further processing filed
16.06.1997Full payment received (date of receipt of payment)
20.11.1995Request for further processing filed
14.11.1995Full payment received (date of receipt of payment)
Request granted
06.12.1995Decision despatched
Fees paidRenewal fee
29.04.1994Renewal fee patent year 03
14.04.1995Renewal fee patent year 04
16.04.1996Renewal fee patent year 05
07.04.1997Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]US4228173  (CAIRNS HUGH, et al) [X] 1-3 * column 5, line 49 - column 6, line 14 *[Y] 4,14-20;
 [XY]WO9009989  (ROTTA RESEARCH LAB [IT]) [X] 1,3 * page 1, paragraph 2 - page 2, paragraph 1 * [Y] 4,14-20;
 [X]EP0416925  (GLAXO GROUP LTD [GB]) [X] 1-3,14,15 * page 3, line 16 - line 37 * * page 4, line 20 - line 58 *
 [X]  - CHARITY C. FOX ET AL., "Modulation of mediator release from human intestinal mast cells by sulfasalazine and 5-aminosalicylic acid", DIGESTIVE DISEASES AND SCIENCES, (199102), vol. 36, no. 2, pages 179 - 184 [X] 1,3 * abstract *
 [Y]  - A.KHANDWALA ET AL., "RHC 3288 (1_mwthyl-2(1,3,4-oxadiazol-2(3H)-one-5-yl)benzimidazole) and related compounds", BIOCHEMICAL PHARMACOLOGY, (1983), vol. 32, no. 22, pages 3325 - 3333 [Y] 4 * abstract * * page 3325, column L *
 [Y]  - PAUL SIMINOFF ET AL., "BL-5255 inhibits mediator release from mast cells and phosphodiesterase activity", INT.J.IMMUNOPHARMACOLOGY, (1982), vol. 4, no. 4, page 343 [Y] 4
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.